Yahoo Web Search

Search results

1. • INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on...

     Morningstar· 6 days ago

     Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) securities between ...

2. • Is Biogen Inc (BIIB) Set to Underperform? Analyzing the Factors

     Guru Focus· 2 days ago

     Long-established in the Drug Manufacturers industry, Biogen Inc (BIIB, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth, and valuation ...

3. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 3 days ago

     Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Biogen Inc. (“Biogen” or the “Company”) ...

4. • BIIB (NASDAQ) FRAUD ALERT: Biogen Inc. Investors who Lost Money are Encouraged to Contact BFA Law...

     Benzinga· 4 days ago

     NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (NASDAQ:BIIB) Securities Class Action Lawsuit. If you

5. • 

     Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder

     Benzinga via Yahoo Finance· 5 days ago

     On Thursday, the European Commission granted marketing authorization under exceptional circumstances...

6. • 

     Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody

     Zacks via Yahoo Finance· 5 days ago

     Biogen’s stock was up 2.6% on Thursday in response to Qalsody’s approval in the EU. Biogen’s < ...

7. • 

     Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?

     Investor's Business Daily· 6 days ago

     Alzheimer's Treatment News Hits LLY Stock Eli Lilly is angling for FDA approval of donanemab, a...

8. • Small Business - Picayune Item | Picayune Item

     The Picayune Item· 2 days ago

     The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District ...

9. • BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with...

     Benzinga· 3 days ago

     SAN DIEGO, June 02, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Biogen Inc. (NASDAQ:BIIB) securities between February 3, 2022 and February 13, 2024, both

10. • Why Is Alkermes (ALKS) Down 2.7% Since Last Earnings Report?

      Zacks· 5 days ago

      Free Report) . Will the recent negative trend continue leading up to its next earnings release, or is Alkermes due for a breakout? Before we dive into how investors and analysts have reacted ...